Skip to main navigation
The link is opening in a new window or tab that may or may not accessible
Opens an external site
Opens an external site in a new window
Pre-Header Contact
800-449-3353
|
custserv@rockwellmed.com
|
Footer Socials
Pre-Header Menu
Careers
|
Contact Us
Client Header Links
Home
Our Company
Mission & Values
Management Team
Board of Directors
Compliance and Ethics
Contact
OUR COMPANY
Improving patient outcomes with innovative drug therapies.
Pipeline
Technology Platform
Pipeline
Leveraging our propriety drug platform, ferric pyrophosphate citrate.
Hemodialysis Products
Supporting Dialysis Providers
Concentrates & Cleaners
DIALYSIS PRODUCTS
Committed to providing life-saving and cost-effective therapies to the dialysis community.
Investors
Press Releases
Events & Presentations
Corporate Governance
Management
Annual Meeting
Financial Information
SEC Filings
Annual Reports
Quarterly Results
Key Ratios
Financial Statements
Stock Information
Historic Stock Lookup
Investment Calculator
Dividend History
Analyst Coverage
Ownership Profile
Investor FAQs
Contact Us
Shareholder Tools
INVESTOR CENTER
Strategies to deliver value for the patients we serve, the medical community, our employees and shareholders.
Investor Relations
Events Details
Main navigation
Investor Home
Press Releases
Events & Presentations
Corporate Governance
Management
Annual Meeting
Financial Information
SEC Filings
Annual Reports
Quarterly Results
Key Ratios
Financial Statements
Stock Information
Historic Stock Lookup
Investment Calculator
Dividend History
Analyst Coverage
Ownership Profile
Investor FAQs
Contact Us
Shareholder Tools
Rockwell Medical 2022 Q2 Results Call
Aug 15, 2022 at 8:00 AM EDT
Listen to Webcast
Shareholder Tools
Snapshot
Snapshot
Email Alerts
Email Alerts
RSS News Feeds
RSS News Feeds
